Clairity is an healthcare technology company developing image-based risk prediction for breast cancer. Its Clairity Breast platform uses a patient’s screening mammogram to predict a woman’s five-year risk of developing breast cancer, providing a validated risk assessment to support early detection and prevention efforts. The company is focused on translating radiology imaging into actionable risk insights and is based in Boston, Massachusetts, with ongoing initiatives to deploy its FDA-authorized technology within health systems.
No recent deals for this company.